Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
22 07 2020
Historique:
received: 30 04 2020
accepted: 13 07 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 14 10 2021
Statut: epublish

Résumé

Chronic kidney disease (CKD) and kidney stones are common in Taiwan; in particular, CKD has a high prevalence but low self-awareness rate. CKD-related risk factors such as diabetes, hypertension, and nephrotoxic drugs are well-known and uncontested; however, kidney stones are relatively less studied and easily overlooked as a risk factor. The objective of this study was to investigate whether kidney stones are a risk factor for CKD. We conducted a nationwide population-based matched cohort study to assess the risk of incident CKD in people with kidney stones. Data on incident stones formers in the year 2001-excluding those with a history of CKD-were obtained from Taiwan's National Health Insurance database. Stone formers were matched (1:4) to control subjects according to sex, age, and index date. The total observation period of the study was 10 years, and the primary end-point was the occurrence of CKD. Student's t-test and Chi-squared test were used to compare continuous and categorical data, respectively. Logistic regression was used to calculate the odds ratio of kidney stone patients with incident CKD relative to the control group. Cox proportional hazard regression model was used to obtain the hazard ratio for development of incident CKD among patients with kidney stones. The incidence of CKD in the kidney stone cohort was 11.2%, which was significantly higher than that of the control group (P < .001). Survival analysis showed that the stones cohort was 1.82 times more likely to experience CKD than the controls. Age, sex, hypertension, diabetes mellitus, and hyperlipidemia increased the risk of CKD incidence (1.04, 1.27, 1.55, 3.31, and 1.25 times, respectively). Kidney stones are a definite risk factor for CKD; therefore, patients with stones are suggested to undergo regular renal function monitoring and receive appropriate treatment to avoid CKD.

Sections du résumé

BACKGROUND
Chronic kidney disease (CKD) and kidney stones are common in Taiwan; in particular, CKD has a high prevalence but low self-awareness rate. CKD-related risk factors such as diabetes, hypertension, and nephrotoxic drugs are well-known and uncontested; however, kidney stones are relatively less studied and easily overlooked as a risk factor. The objective of this study was to investigate whether kidney stones are a risk factor for CKD.
METHODS
We conducted a nationwide population-based matched cohort study to assess the risk of incident CKD in people with kidney stones. Data on incident stones formers in the year 2001-excluding those with a history of CKD-were obtained from Taiwan's National Health Insurance database. Stone formers were matched (1:4) to control subjects according to sex, age, and index date. The total observation period of the study was 10 years, and the primary end-point was the occurrence of CKD. Student's t-test and Chi-squared test were used to compare continuous and categorical data, respectively. Logistic regression was used to calculate the odds ratio of kidney stone patients with incident CKD relative to the control group. Cox proportional hazard regression model was used to obtain the hazard ratio for development of incident CKD among patients with kidney stones.
RESULTS
The incidence of CKD in the kidney stone cohort was 11.2%, which was significantly higher than that of the control group (P < .001). Survival analysis showed that the stones cohort was 1.82 times more likely to experience CKD than the controls. Age, sex, hypertension, diabetes mellitus, and hyperlipidemia increased the risk of CKD incidence (1.04, 1.27, 1.55, 3.31, and 1.25 times, respectively).
CONCLUSION
Kidney stones are a definite risk factor for CKD; therefore, patients with stones are suggested to undergo regular renal function monitoring and receive appropriate treatment to avoid CKD.

Identifiants

pubmed: 32698782
doi: 10.1186/s12882-020-01950-2
pii: 10.1186/s12882-020-01950-2
pmc: PMC7376912
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

292

Références

Mayo Clin Proc. 1993 Mar;68(3):241-8
pubmed: 8474265
Ann Epidemiol. 2004 Mar;14(3):222-8
pubmed: 15036227
Am J Kidney Dis. 2011 Jan;57(1 Suppl 1):A8, e1-526
pubmed: 21184928
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
J Am Soc Nephrol. 2000 Jan;11(1):177-82
pubmed: 10616853
BJU Int. 2006 Jun;97(6):1285-90
pubmed: 16686727
AJR Am J Roentgenol. 1988 Feb;150(2):311-5
pubmed: 3257316
Health Policy. 1997 Mar;39(3):225-39
pubmed: 10165463
Br J Urol. 1991 Feb;67(2):203-5
pubmed: 2004237
Kidney Int. 2005 Jun;67(6):2089-100
pubmed: 15882252
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8
pubmed: 28236831
Clin J Am Soc Nephrol. 2009 Apr;4(4):804-11
pubmed: 19339425
Urol Res. 2007 Apr;35(2):83-7
pubmed: 17310350
Am J Kidney Dis. 2004 Nov;44(5):799-805
pubmed: 15492945
J Urol. 2013 Jun;189(6):2158-63
pubmed: 23313204
Invest Urol. 1976 Mar;13(5):346-50
pubmed: 815197
JAMA. 1995 Mar 8;273(10):777-81
pubmed: 7861571
Lancet. 2008 Jun 28;371(9631):2173-82
pubmed: 18586172
Am J Kidney Dis. 2001 Feb;37(2):233-43
pubmed: 11157364
Int J Pediatr Nephrol. 1985 Jan-Mar;6(1):13-6
pubmed: 3997367
J Urol. 2006 Aug;176(2):600-3; discussion 603
pubmed: 16813897
N Engl J Med. 1991 Sep 5;325(10):681-6
pubmed: 1908057

Auteurs

Tzung-Fang Chuang (TF)

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, Nantou, Taiwan.
Central Taiwan University of Science and Technology; Department of Healthcare Administration, No. 666, Buzi Rd., Beitun Dist, Taichung City, 406, Taiwan.

Hung-Chang Hung (HC)

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, Nantou, Taiwan.
Central Taiwan University of Science and Technology; Department of Healthcare Administration, No. 666, Buzi Rd., Beitun Dist, Taichung City, 406, Taiwan.

Shu-Fen Li (SF)

Central Taiwan University of Science and Technology; Department of Healthcare Administration, No. 666, Buzi Rd., Beitun Dist, Taichung City, 406, Taiwan.

Mei-Wen Lee (MW)

Central Taiwan University of Science and Technology; Department of Healthcare Administration, No. 666, Buzi Rd., Beitun Dist, Taichung City, 406, Taiwan.

Jar-Yuan Pai (JY)

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Chin-Tun Hung (CT)

Central Taiwan University of Science and Technology; Department of Healthcare Administration, No. 666, Buzi Rd., Beitun Dist, Taichung City, 406, Taiwan. cthung@ctust.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH